That obscure object of desire

  • by: |
  • 08/27/2010
What is that obscure object of desire?  Could it be ... risk information?

In the belief that facts drive guidance and oversight on behalf of the public health, some interesting and important data on attitudes towards risk and benefit in DTC ads.

(Note – key word is “ads” – not social media.)

Attitudes toward Risk/Benefit Info in DTC Ads

TV       Magazine      Online

 Risk

Seen/heard                                            79%         48%              37%

Pay a lot/some attention                         76%         66%              69%

Say it is very/somewhat useful                76%          75%              75%

Benefits

Seen/heard                                           73%           52%              54%

Pay a lot/some attention                        63%           63%              57%

Say it is very/somewhat useful                75%           76%              76%

Source: Rodale, "2010 DTC Study," July 15, 2010

What does this tell us?  Well, on the “benefit” side, it seems to suggest that consumers rank all three media equally when it comes to utility (“say it is very/somewhat useful”).  And while TV and print still seem to have an edge in the “pay a lot/some attention” department (at 63%), online ads are a very close show at 57%.  Decimal dust?  Not when you’re doing ROI calculations -- but it’s really only a half-game lead – and the momentum is shifting online's way.

In the “seen/heard” department, TV leads both print and online – but online beats print – further adding to the “death of print” argument.

With “utility” almost even across the board (76%/75%/75%), it’s the risk stats that give pause for reflection. 

While 79% have “seen/heard” risk information on TV ads (not surprising since the viewer passively receives it whether they want to or not), and print (48%) out-strips online (37%). 

But the race tightens in the “pays a lot/some attention" – where TV still leads (we are, after all, glued to the couch), but online (69%) out paces print (66%).  Among other conclusions, this points to (1) the well-documented inadequacies of the brief summary (i.e., neither brief nor a summary) and (2) the greater desire of the online ad viewer to click to risk information.  Put another way –nearly 70% of online ad viewers actively click-through to risk information.  Pretty impressive – and even more so considering this data was collected well after the November 2009 FDA letters on sponsored Google links.

Food for thought.

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog